618
Views
9
CrossRef citations to date
0
Altmetric
Review

Long-term management of GERD in the elderly with pantoprazole

, &
Pages 85-92 | Published online: 19 Oct 2022

References

  • Ahnfeldt-MollerupIFlyGFKnudsenMH1997Dyspepsia in general practice. A study among users of anti-ulcer agentsUgeskr Laeger159377269214053
  • ArmstrongCPBlowerAl1997Non-steroidal anti-inflammatory drugs and life threatening of peptic ulcerationGut28527323596334
  • BardanKDMuller-LissnerSBigardA1999Symptomatic gastro-oesophagel reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidineBMJ318502710024259
  • BardhanKDBishopAEPolakJM2005Pantoprazole in severe acid peptic disease: the effectiveness and safety of 5 years’ continuous treatmentDig Liv Dis371022
  • BerardiRR2006A critical evaluation of proton pump inhibitors in the treatment of esophageal reflux diseaseAm J Managed Care69 supplS491S503
  • Bianchi PorroGLazzaroniMImbresiV2000Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double blind, parallel-group studyDig Liver Dis32201810975769
  • BoutetRWilcockMMackenzieI1999Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the isles of SicilyAliment Pharmacol Ther138131710383512
  • BrandiGBiavatiBCalabreseC2006Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosaAm J Gastroenterol10117566116780553
  • CalabreseCBortolottiMFabbriA2005Reversibility of GERD ultrastructural alterations and relief of symptoms after Omeprazole treatmentAm J Gastroenterol1005374215743348
  • CalabreseCFabbriAAreniA2005Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapyWJG1176576016437694
  • CheerSMPrakashAFauldsD2003Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disordersDrugs631013312487624
  • ChenTJChouLFHwangSJ2003Trends in prescribing proton pump inhibitors in Taiwan: 1Int J Clin Pharmacol Ther412071212776811
  • CollenMJAbdulianJDChenYK1995Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapyAm J Gastroenterol90105377611195
  • DentJBrunJFendrickAM1999An evidence-based appraisal of reflux disease management. The Genval Workshop ReportGut44suppl 2S1S1610741335
  • DevaultKR2006Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburnAliment Pharmacol Ther23suppl 133916483268
  • DimenasECarlssonGGliseH1996Relevance of normal values as part of the documentation of quality of life instruments for use in upper gastrointestinal diseaseScand J Gastroenterol Suppl2218139110389
  • DonnellanCSharmaNPrestonC2005Medical treatments for the maintenance therapy of reflux esophagitis and endoscopic negative reflux diseaseCochrane Database Syst RevCD00324515846653
  • DupasJLHouchePHGiret d’OrsayG1998Pantoprazole versus lansoprazole in patients with reflux esophagitis. Meta-analysis of two French studiesDigestion59suppl 2A604
  • EarnestDLRobinsonM1999Treatment advances in acid secretory disorders: The promise of rapid symptom relief with disease resolutionAm J Gastroenterol94supplS18S24
  • el-SeragHBSonnenbergA1997Associations between different forms of gastro-esophageal reflux diseaseGut4159499414963
  • EscourrouJDeprezPSaggioroA1999Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitisAliment Pharmacol Ther1314819210571605
  • FittonAWisemanL1996Pantoprazole: a review of its pharmacologic properties and therapeutic use in acid related disordersDrugs51460828882382
  • FrestonJW1997Long-term acid control and proton pump inhibitors: interactions and safety issues in perspectiveAm J Gastroenterol92S51S57
  • GarnettWR1998Considerations for long-term use of proton pump inhibitorsAm J Health Syst Pharm552268799825878
  • GoudieBMMcKenziePECiprianoJ1996Repeat prescribing of ulcer healing drugs in general practice-prevalence and underlying diagnosisAliment Pharmacol Ther10147508730242
  • HetzelDJDentJReedWD1998Healing and relapse of sever peptic esophagitis after treatment with omeprazoleGastroeneterology9590312
  • HunginAPRubinGO’FlanaganH1999Factors influencing compliance in long-term proton pump inhibitor therapy in general practiceBr J Gen Pract49463410562747
  • HunginAPRubinGPO’FlanaganH1999Co-prescription of potentially interacting H2 receptor blockers and proton pump inhibitors with warfarin in general practicePostgrad Med J75721210567597
  • HunginAPRubinGPO’FlanaganH1999Long term prescribing of proton pump inhibitors in general practiceBr J Gen Pract49451310562744
  • HurenkampGJGrundmeyerHGBindelsPJ2002How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practicesJ Fam Pract51241511978235
  • JacobsonBCFerrisTGSheaTL2003Who is using chronic acid suppression therapy and why?Am J Gastroenterol9851812526936
  • JalvingMKoornstraJJWesselingJ2006Increased risk of fundic gland polyps during long-term proton pump inhibitor therapyAliment Pharmacol Ther2413414817059515
  • JohnssonFMoumBVilienM2002On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazoleScand J Gastroenterol37642712126240
  • Kaplan-MachlisBSpieglerGERevickiDA1999Health-related quality of life in primary carepatients with gastroesophageal reflux diseaseAnn Pharmacother331032610534213
  • KaspariSKupcinskasLHeinzeH2005Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux diseaseEur J Gastroenterol Hepatol179354116093871
  • KatzPO1999Treatment of gastroesophageal reflux disease: use of algorithms to aid in managementAm J Gastroenterol94supplS3S1010565603
  • KovacsTWilcoxCMDevaultK2002Pantoprazole US GERD Study Group B: comparison of efficacy pf Pantoprazole vs nizatidine in the treatment of erosive esophagitis: a randomized, active-controlled, double-blind studyAliment Pharmacol Ther1620435212452936
  • LaineLAhnenDMcClainC2000Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitorsAliment Pharmacol Ther146516810848649
  • LassenAHallasJSchaffalitzky De MuckadellOB2004Use of anti-secretory medication: a population-based cohort studyAliment Pharmacol Ther205778315339329
  • LiebermanD1987Medical therapy for chronic reflux esophagitis. Long term follow upArch Int Med1471717203116959
  • MaekavaTKinoshitaYOkadaA1998Relationship between severity and symptoms of reflux esophagitis in the elderly patients in JapanJ Gastroenterol Hepatol13927309794192
  • MajumdarSRSoumeraiSBFarrayeFA2003Chronic acid-related disorders are common and under investigatedAm J Gastroenterol9824091414638341
  • MoldJVReedLEDavisAB1991Prevalence of gastroesophageal reflux in elderly patients in a primary care settingAm J Gastroenterol86965701858762
  • MonnikesHPfaffenbergerBGatzG2005Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg Pantoprazole or 20 mg EsomeprazoleDigestion71152815870503
  • MoosnerJKoopHPorstH1997One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux patients with healed reflux oesophagitisAliment Pharmacol Ther111087929663834
  • MoretzsohnLDBritoEMReisMSF2002Assessment of effectiveness of different dosage regimens of Pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitisArch Gastroenterol391235
  • MullerPSimonB1998The action of proton pump inhibitor pantoprazole against acetylsalicylic acid-induced gastroduodenopathy in comparison to ranitidine. An endoscopic controlled double blind comparisonArzneimittelforshung4848259638315
  • OllyoJBMonnierPFontollietC1993The natural history, prevalence and incidence of reflux esophagitisGullet3Suppl 1310
  • PaliAHunginSRaghunathA1994Managing gastro-oesophageal reflux disease in the older patientDigestion69suppl 11724
  • PilottoAFranceschiMParisF2005Recent advances in the treatment of GERD in the elderly: focus on proton pump inhibitorsInt J Clin Pract591204916178989
  • PilottoALeandroGFranceschiM2002Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow up studyAm J Ther929530012115018
  • PilottoALeandroGFranceschiM2003Short and long term therapy for reflux esophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazoleAliment Pharmacol Ther17139940612786634
  • PrachATMcGilchristMMMurrayFE1999Prescription of acid suppressing drugs in relation to endoscopic diagnosis: a record-linkage studyAliment Pharmacol Ther1339740510102974
  • RaghunathASHunginAPS2004Long-term prescribing of proton pump inhibitors in primary care: a cross-sectional surveyGut53suppl. 1A24
  • RaghunathASMorainCOMCloughlinRC2005Review article: the long-term use of proton pump inhibitorsAlimentary Pharmacol Ther22suppl 15563
  • RaihaIHietanenESouranderL1991Simptoms of gastroesophageal reflux disease in elderly peopleAge Ageing20365701755393
  • RaihaIJImpivaaraOSeppalaM1992Prevalence and characteristics of symptomatic gastroesophageal reflux in the elderlyJ Am Geriatric Soc40120911
  • RegulaJButrukE2006Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazoleAm J Gastroeneterol101174755
  • RichardsonPHavkeyCJStackWA1998Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disordersDrugs56307359777309
  • RichterJEFragaPMackM2004Prevention of erosive oesophagitis relapse with pantoprazoleAliment Pharmacol Ther205677515339328
  • RichterJE2000Gastroesophageal reflux disease in the older patient: presentation, treatment and complicationsAm J Gastroenterol953687310685737
  • RobertsSJBatemanDN1995Prescribing of antiacids and ulcer healing drugs in primary care in the north of EnglandAliment Pharmacol Ther9137437605853
  • RubinGPContractorBBrambleMG1995The use of long term acid-suppression therapyBr J Clin Pract49119207779658
  • RyderSDO’ReillySMillerRJ1994Long term acid suppressing treatment in general practiceBMJ308827308167491
  • SachsGShinJMBesanconM1993The continuing development of gastric acid pump inhibitorsAlimen Pharmacol Ther7412
  • SandmarkSCarlssonRFausaO1998Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double blind randomized Scandinavian multicenter studyScand J Gastroenterol23625323041558
  • ScholtenTDekkersCPMSchutzeK2005On-demand therapy with pantoprazole 20 mg as effective long term management of reflux disease in patients with mild GERD: the Orion trialDigestion72768516113546
  • ShinJMSachsG2002Restoration of acid secretion following treatment with proton pump inhibitorsGastroenterology12315889712404233
  • SinghGTriadaphilopoulosG1999Epidemiology of NSAID-induced GI complicationsJ Reumatol26suppl 261824
  • StanghelliniVArmstrongDMonnikesH2005Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studiesDigestion711455115870502
  • StupnickiTDietrichKGonzales CarroP2004Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patientsDigestion7061915297779
  • StupnickiTDietrichKGonzales-CarroP2003Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patientsDigestion6819820814707396
  • TsaiHHChapmanRShepherdA2004Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND StudyAliment Pharmacol Ther206576515352914
  • VanderhoffBTTahboubRM2002Proton pump inhibitors: an updateAm Fam Physic6627380
  • van ZylJvan RensburgCViewegW2004Efficacy and safety of Pantoprazole versus Ranitidine in the treatment of Patients with symptomatic gastroesophageal reflux diseaseDigestion7061915297779
  • VenablesTLNewlandRDPatelAC1997aOmeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophagel reflux disease in general practiceScand J Gastroenterol32965739361167
  • VenablesTLNewlandRDPatelAC1997bMaintenance treatment for gastro-esophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practiceScand J Gastroenterol32627329246699
  • VetvikKStraandJ2001Acid-related disease in the population of two Norwegian municipalities—diagnosis and drug therapyTidsskr Nor Laegeforen1215576211301609
  • VicariFBelinJMarekL1998Pantoprazole 40 mg versus omeprazole 20 mg in the treatment of reflux esophagitis: results of French multicenter double-blind comparative trialGastroenterology114suppl 1A324